Your browser doesn't support javascript.
loading
EGFR Inhibitors Plus Bevacizumab are Superior Than EGFR Inhibitors Alone as First-Line Setting in Advanced NSCLC With EGFR Mutations and BIM Deletion Polymorphisms (BIM-CLICaP).
Cardona, Andrés F; Ordóñez-Reyes, Camila; Ruiz-Patiño, Alejandro; Garcia-Robledo, Juan Esteban; Barron, Lucia Zatarain; Recondo, Gonzalo; Rojas, Leonardo; Corrales, Luis; Martín, Claudio; Barrón, Feliciano; Sotelo, Carolina; Rodríguez, July; Ricaurte, Luisa; Rolfo, Christian; Ávila, Jenny; Mayorga, Diana; Archila, Pilar; Otero, Jorge; Mas, Luis; Bermudez, Maritza; Gamez, Tatiana; Carranza, Hernán; Vargas, Carlos; Rosell, Rafael; Arrieta, Oscar.
Afiliação
  • Cardona AF; Clinical and Translational Oncology Group, Clínica del Country, Bogotá, Colombia.
  • Ordóñez-Reyes C; Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia.
  • Ruiz-Patiño A; Molecular Oncology and Biology Systems Research Group (Fox-G/ONCOLGroup), Universidad el Bosque, Bogotá, Colombia.
  • Garcia-Robledo JE; Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia.
  • Barron LZ; Molecular Oncology and Biology Systems Research Group (Fox-G/ONCOLGroup), Universidad el Bosque, Bogotá, Colombia.
  • Recondo G; Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia.
  • Rojas L; Molecular Oncology and Biology Systems Research Group (Fox-G/ONCOLGroup), Universidad el Bosque, Bogotá, Colombia.
  • Corrales L; Clinical Research Center, Fundación Valle del Lili, Cali, Colombia.
  • Martín C; Thoracic Oncology Unit, Instituto Nacional de Cancerología, México City, México.
  • Barrón F; Thoracic Oncology Section, Centro de Educación Médica e Investigaciones Clínicas-CEMIC, Buenos Aires, Argentina.
  • Sotelo C; Clinical and Translational Oncology Group, Clínica del Country, Bogotá, Colombia.
  • Rodríguez J; Molecular Oncology and Biology Systems Research Group (Fox-G/ONCOLGroup), Universidad el Bosque, Bogotá, Colombia.
  • Ricaurte L; Clinical Oncology Department, Clínica Colsanitas, Bogotá, Colombia.
  • Rolfo C; Oncology Unit, Hospital San Juan de Dios/Centro de Investigación y Manejo del Cáncer (CIMCA), San José, Costa Rica.
  • Ávila J; Medical Oncology Department, Thoracic Oncology Section, Instituto Fleming, Buenos Aires, Argentina.
  • Mayorga D; Thoracic Oncology Unit, Instituto Nacional de Cancerología, México City, México.
  • Archila P; Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia.
  • Otero J; Molecular Oncology and Biology Systems Research Group (Fox-G/ONCOLGroup), Universidad el Bosque, Bogotá, Colombia.
  • Mas L; Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia.
  • Bermudez M; Molecular Oncology and Biology Systems Research Group (Fox-G/ONCOLGroup), Universidad el Bosque, Bogotá, Colombia.
  • Gamez T; Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia.
  • Carranza H; Molecular Oncology and Biology Systems Research Group (Fox-G/ONCOLGroup), Universidad el Bosque, Bogotá, Colombia.
  • Vargas C; Pathology Department, Mayo Clinic, Rochester, MN.
  • Rosell R; Center for Thoracic Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Arrieta O; Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia.
JCO Precis Oncol ; 5: 839-848, 2021 11.
Article em En | MEDLINE | ID: mdl-34994616
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Receptores ErbB / Bevacizumab / Proteína 11 Semelhante a Bcl-2 / Antineoplásicos Imunológicos / Neoplasias Pulmonares Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: JCO Precis Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Colômbia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Receptores ErbB / Bevacizumab / Proteína 11 Semelhante a Bcl-2 / Antineoplásicos Imunológicos / Neoplasias Pulmonares Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: JCO Precis Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Colômbia